Research News

As 2024 comes to a close, we want to recognize the UNC Department of Medicine faculty ranked on Expertscape in their areas of expertise. Over 40 DOM faculty have been internationally ranked. Expertscape ranks researchers based on the quantity and significance of their published studies in a specific topic, with a focus on their authorship and impact … Read more

Jill Cunnup, Administrative Director for Clinical Research, Kelsey Haywood, Pulmonary Diseases and Critical Care Medicine Research Program Director, Alex Kass, MSN, MBA, RN, CDCES, Caleb Hemphill and Brett Phillips, MA,PMP, CCRP, attended the Society of Research Administrators conference in Chicago. The conference theme, Breaking Barriers: Together Towards Tomorrow, offered a wide range of sessions, workshops, … Read more

Dr. Janice Hwang Janice Jin Hwang, MD, MHS, Division Chief of Endocrinology and Metabolism, has been awarded a $2.796 million, 5 year, NIH U01 grant to investigate the neurocognitive effects of Type 1 Diabetes (T1D) in children. The project, titled “Mapping Neurocognitive Complications of Pediatric Type 1 Diabetes” is a collaboration among researchers, including Aysenil … Read more

The following Department of Medicine faculty members received the following grants or funding Division of Hematology Steven Grover, PhD, has been awarded a $3.2 million R01 grant from the NIH NHLBI for his research into C1 inhibitors. Joshua Rivenbark, MD, PhD, won the 2024  Agios Hemolytic Anemias Clinical Fellowship Competitive Grant. Division of Geriatric Medicine The CGWEP (Carolina Geriatric … Read more

Raj Kasthuri, MBBS, professor in the UNC Division of Hematology and director of the UNC HHT Center of Excellence, and a team of researchers published their study evaluating the safety and efficacy of pomalidomide for the treatment of Hereditary Hemorrhagic Telangiectasias in the New England Journal of Medicine.  Hereditary Hemorrhagic Telangiectasias (HHT) is an inherited … Read more

A multidisciplinary team of researchers at the University of North Carolina-Chapel Hill, including Prabir Roy-Chaudhury, MD, PhD, nephrologist and the Drs. Ronald and Katherine Falk Eminent Professor in the School of Medicine, are developing a membrane technology that has the potential to significantly miniaturize dialysis equipment. The goal is to provide convenient and effective treatment … Read more

Nigel Key, MD Nigel Key, MD, Harold R. Roberts Distinguished Professor of Medicine in the Division of Hematology, was an invited plenary speaker at the French Congress on Hemostasis 2024 on September 12 in Lille, France. The title of his lecture was “Is tranexamic acid a universal hemostatic agent? What is left to learn about … Read more

(left) Amanda E. Nelson, MD, MSCR, RhMSUS; (right) Leigh F. Callahan, PhD The UNC Core Center for Clinical Research (CCCR) was recently awarded 5-year renewal funding from NIH/NIAMS. The renewed CCCR will be led by co-PIs Amanda E. Nelson, MD, MSCR, RhMSUS, and Leigh F. Callahan, PhD.  The overall goal of the UNC CCCR is … Read more

The following Department of Medicine faculty members received the following grants or funding. Division of Oncology Yohei Hisada, PhD, was awarded $50K for his research in leukemia at the 2024 ISTH conference in Bangkok Brian Miller, MD, received the Melanoma Research Alliance Young Investigator Award for $250k.  Division of Gastrology and Hepatology Aadra Bhatt, PhD … Read more

Erin Steinbach, MD, assistant professor of medicine in the UNC Division of Rheumatology, Allergy & Immunology, recently received a K08 award from the NIH’s National Institute of Allergy and Infectious Diseases for her project, “Revealing the mechanism of increased intestinal epithelial cell barrier permeability in peanut allergy”. This project represents a five-year research career development … Read more

Yohei Hisada, PhD, was awarded $50K for his research in leukemia at the 2024 ISTH conference in Bangkok Yohei Hisada, PhD, an Assistant Professor of Medicine, has been awarded  $50,000 dollars for his research through the International Society on Thrombosis and Haemostasis Fundamental Research Career Development Award in the category of Fundamental Mechanisms of Hemostasis. … Read more

This new study highlights safety and efficacy of Anti-CD30 CAR T-Cell therapy in high-risk lymphoma patients A team comprised mainly of faculty from the Division of Hematology and UNC Lineberger Comprehensive Cancer Center published a groundbreaking phase 1 study in The Lancet Haematology. The study demonstrates the safety and promising activity of anti-CD30 CAR T … Read more